In today’s ACT Brief, we highlight how Bayesian methods are reshaping adaptive trial design, a major eSource partnership is ...
Public-private collaboration and structured evidence consolidation are emerging as critical enablers of regulatory-ready ...
In this video interview, David Morton, PhD, director of biostatistics at Certara, outlines how increasing FDA support is ...
In this video interview, David Morton, PhD, director of biostatistics at Certara, explains how regulatory momentum is ...
Medidata, CRIO Partnership Advances eSource Integration to Improve Data Quality and Trial Efficiency
Medidata has entered a strategic partnership with CRIO to streamline clinical trial data flow by directly integrating ...
In today’s ACT Brief, we examine how the Verana Health-COTA merger is evolving real-world data use, the FDA’s new framework ...
The Patient Advocate Foundation and the PAN Foundation have announced a strategic merger to create the nation’s most ...
In today’s ACT Brief, we highlight how Bayesian methods are gaining operational traction, a major patient advocacy merger is ...
In this episode of the Applied Clinical Trials Podcast, C.K. Wang, MD, chief medical officer at COTA; and Sujay Jadhav, CEO ...
As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...
In this video interview, David Morton, PhD, director of biostatistics at Certara, explains how regulatory momentum is encouraging sponsors to move beyond traditional methods, leveraging Bayesian ...
At SCOPE Summit 2026, site leaders shared how AI is transforming feasibility, patient identification, and enrollment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results